 |
인쇄하기
취소
|
CJ to heighten effort to boost pharmaceutical and biosimilar sectors
CJ Cheiljedang Corp., Korea's leading food manufacturer, has recently unveiled a set of plans to nurture its pharmaceutical and biosimilar sectors as one of CJ’s core businesses.
“We will boost the sales of pharmaceutical and biosimlar products by spending more money in our research and develop (R&D) projects,” said Yoo Young-ho, head of Osong plant, in a press interview.
He said that CJ ...
“We will boost the sales of pharmaceutical and biosimlar products by spending more money in our research and develop (R&D) projects,” said Yoo Young-ho, head of Osong plant, in a press interview.
He said that CJ ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.